Genomics has been a largely homogeneous field--both with respect to the researchers and the individuals whose data has been collected. Carlos Bustamante, Professor at Stanford University and F-Prime Venture Partner, whose work studies populations of diverse ancestry, claims that COVID has brought these disparities to light and that we have a unique opportunity to sequence the next generation of babies as one step towards more equitable precision medicine and drug development. He also discusses how the patient, as the healthcare consumer, will soon govern what solutions are adopted, including digital medicine and continuous tracking.

Check out the glossary of terms, definitions, and resources (and get a sneak peak of the future conversations lined up!) here: bit.ly/datapulse-glossary